Clinical Study

Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State

Table 3

Procoagulation parameters, markers of platelet activation, and blood coagulation tests in responders.

ParametersCurcuminoids cocktail ()Vitamin E cocktail ()
BaselineMonth 6Month 12Month 15BaselineMonth 6Month 12Month 15

Procoagulation parameters
 PF3-like activity (A405) 1.15 ± 0.120.86 ± 0.090.78 ± 0.10a1.16 ± 0.161.24 ± 0.100.84 ± 0.08b0.67 ± 0.06b1.17 ± 0.12
 PS+RBC (%)4.49 ± 0.711.90 ± 0.36b1.64 ± 0.44b4.18 ± 0.795.41 ± 1.032.10 ± 0.65a1.73 ± 0.71b3.55 ± 1.28
 PS+Plt (%)1.02 ± 0.320.56 ± 0.160.40 ± 0.141.16 ± 0.320.61 ± 0.150.31 ± 0.060.24 ± 0.04a0.61 ± 0.16
Platelet activation
 CD62 expression (%)21.9 ± 4.09.0 ± 1.9b13.8 ± 3.218.1 ± 3.916.9 ± 3.17.8 ± 2.112.3 ± 3.320.0 ± 4.6
 PAC1 expression (%)3.8 ± 1.00.9 ± 0.3b2.0 ± 0.6a2.4 ± 0.74.6 ± 1.11.1 ± 0.5a2.7 ± 1.04.1 ± 1.5
Blood coagulation
 PT (s)15.1 ± 0.214.0 ± 0.2b14.4 ± 0.214.5 ± 0.414.9 ± 0.213.9 ± 0.2b14.2 ± 0.2b14.6 ± 0.2
 aPTT (s)31.3 ± 0.628.9 ± 0.6a29.3 ± 0.8a29.6 ± 0.830.8 ± 0.329.1 ± 0.4b29.0 ± 0.5b29.4 ± 0.5a
 PT/aPTT 0.50 ± 0.010.47 ± 0.01a0.49 ± 0.010.50 ± 0.010.50 ± 0.010.47 ± 0.01a0.49 ± 0.010.49 ± 0.01

The values represent mean ± standard error of the mean.
aPTT: activated partial thromboplastin time; CD62: platelet surface P-selectin; PAC1: activated glycoprotein IIb/IIIa; PF3: platelet factor 3; Plt: platelet; PS+: phosphatidylserine-positive; PT: prothrombin time; RBC: red blood cells.
compared with baseline, compared with baseline.